SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

HUTCHMED Says FDA Grants Sovleplenib Orphan Drug Designation

The FDA granted orphan drug designation to HUTCHMED’s sovleplenib for autoimmune hemolytic anemia.

Related stories